market could span Culture-independent techniques, Large-scale implementation and Enrichment, and isolation and
cultivation of microorganisms.
The key applications that could be explored in the market include Cosmetics, Pharmaceuticals, Nutritional
Supplements, and Fine Chemical. The “Cosmetics” segment led the marine biotechnology market in 2017 and will
continue to lead in the forecast period. The key factors that may be attributed to the growth of market includes
increasing investment by key players and other aspects like dietary and healthy supplements because they are rich in
proteins, amino acids, vitamins, and minerals etc. The market could be explored based on the end user as
Healthcare/Biotechnology, Industrial products, Energy & Infrastructure, Consumers’ products, and Others.
North America accounted for the major share of the marine biotechnology market in 2017 and will continue to lead in
the forecast period. The factors that could be attributed to the growth include growing funding for R&D to develop
novel drugs from bio-based products, increasing focus on the manufacture of algae-derived biotechnology and
increasing the consciousness about the benefits of marine-derived products. North America is followed by Asia-Pacific
and European region.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/marine-biotechnology-market/request-sample
Some of the key players that fuel the growth of the marine biotechnology market comprise CP Kelco US Inc, Aker
BioMarin, Sea Run Holdings Inc., Elan Corp, GlycoMar Ltd., FMC Corp., Lonza Group Ltd., MariCal, Tequesta Marine
Biosciences, New England Biolabs Inc., Mari Nova, and PML Applications Ltd. The leading companies are taking up
partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Market Segment:
This report focuses on the global top players, covered
• Marinova
• NEB
• BiotechMarine
• GlycoMar
• Marine Biotech
• Nofima